Jeil Pharmaceutical Co.,Ltd (KRX: 271980)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,450
-320 (-2.72%)
Dec 20, 2024, 3:30 PM KST
-33.28%
Market Cap 166.84B
Revenue (ttm) 697.64B
Net Income (ttm) -35.82B
Shares Out 14.57M
EPS (ttm) -2,459.00
PE Ratio n/a
Forward PE n/a
Dividend 50.00 (0.44%)
Ex-Dividend Date Dec 27, 2024
Volume 9,886
Open 11,690
Previous Close 11,770
Day's Range 11,290 - 11,720
52-Week Range 10,120 - 19,870
Beta 1.12
Analysts n/a
Price Target n/a
Earnings Date Mar 13, 2025

About Jeil Pharmaceutical Co.,Ltd

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1959
Employees 1,000
Stock Exchange Korea Stock Exchange
Ticker Symbol 271980
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.